These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36326314)

  • 1. Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia.
    Sancer O; Koşar PA; Tefebaşı MY; Ergün O; Demir M; Koşar A
    Turk J Med Sci; 2022 Jun; 52(3):788-795. PubMed ID: 36326314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.
    Kang HW; Byun YJ; Moon SM; Kim K; Piao XM; Zheng CM; Moon SK; Choi YH; Kim WT; Kim YJ; Lee SC; Yun SJ; Kim WJ
    Investig Clin Urol; 2022 Mar; 63(2):238-244. PubMed ID: 35244999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Promising Pathway in Aggressive Prostate Cancer: Treg/mir-let8c/lin28b.
    Akalin I; Erol B; Aslan E; Ozkanli SS; Efiloglu O; Yildirim S; Caskurlu T; Yildirim A; Karaman MI
    Arch Esp Urol; 2022 Jun; 75(5):459-466. PubMed ID: 35983819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
    Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
    Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
    PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
    Dülgeroğlu Y; Eroğlu O
    Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
    Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
    Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets.
    Rane JK; Scaravilli M; Ylipää A; Pellacani D; Mann VM; Simms MS; Nykter M; Collins AT; Visakorpi T; Maitland NJ
    Eur Urol; 2015 Jan; 67(1):7-10. PubMed ID: 25234358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression profiles in benign prostatic hyperplasia.
    Zhang N; Li Z; Bai F; Ji N; Zheng Y; Li Y; Chen J; Mao X
    Mol Med Rep; 2018 Mar; 17(3):3853-3858. PubMed ID: 29359788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis.
    Leite KR; Tomiyama A; Reis ST; Sousa-Canavez JM; Sañudo A; Camara-Lopes LH; Srougi M
    Urol Oncol; 2013 Aug; 31(6):796-801. PubMed ID: 21880514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially expressed microRNAs in peripheral blood mononuclear cells of non-segmental vitiligo and their clinical significance.
    Zhang Z; Yang X; Liu O; Cao X; Tong J; Xie T; Zhang J; Peng Y
    J Clin Lab Anal; 2021 Feb; 35(2):e23648. PubMed ID: 33169883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential of hsa-mir-106b-5p as Liquid Biomarker in Prostate Cancer Patients in Indonesia.
    Bonnu CH; Ramadhani AN; Saputro RB; Sesotyosari SL; Danarto R; Astuti I; Haryana SM
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):837-842. PubMed ID: 33773548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
    Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Prostate-Specific Antigen Combined with Plasma miRNA-149 Expression in Patients with Prostate Cancer Based on Experimental Data and Bioinformatics.
    Wang H; Yang L; Mi Y; Wang Y; Ma C; Zhao J; Liu P; Gao Y; Li P
    Contrast Media Mol Imaging; 2022; 2022():6094409. PubMed ID: 35935308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia-archival samples study.
    Pełka K; Klicka K; Grzywa TM; Gondek A; Marczewska JM; Garbicz F; Szczepaniak K; Paskal W; Włodarski PK
    Histochem Cell Biol; 2021 Mar; 155(3):423-433. PubMed ID: 33331954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
    Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
    Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
    Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.